万古霉素血药浓度监测和肾毒性及临床疗效关系的研究
本文选题:万古霉素 切入点:肾毒性 出处:《现代中西医结合杂志》2016年29期
【摘要】:目的探讨万古霉素血药浓度与肾毒性之间的关系,对患者预后的影响及增加肾毒性的危险因素。方法选择符合标准的住院期间静脉用万古霉素且监测血药浓度的患者105例,收集患者性别、年龄、感染部位、科室分布情况、病原学检查情况等资料,统计万古霉素谷浓度、峰浓度及不同谷浓度下肾毒性发生率;根据万古霉素用药期间是否出现肾毒性分为肾损伤组与非损伤组,比较2组万古霉素谷浓度、峰浓度,用药前后血肌酐值、肌酐清除率,合并疾病情况,同时使用抗生素及其他药物情况。结果 105例患者共行血药浓度监测125例次,谷浓度20 mg/L与≥20 mg/L的肾毒性发生率分别为7.57%和46.15%,二者比较差异有统计学意义(P0.05)。肾损伤组的谷浓度中位数达26.1 mg/L,非损伤组中位数13.2 mg/L,肾损伤组明显高于非损伤组(P0.05);肾损伤组合并糖尿病比例和使用升压药比例均明显高于非损伤组(P均0.05)。革兰阳性菌感染者40例经万古霉素治疗后,临床有效率为57.5%;细菌学清除率32.5%,未清除率20%,病原菌转为革兰阴性菌3例,未复查16例。结论高的万古霉素谷浓度可增加肾毒性的风险,谷浓度≥20mg/L肾毒性发生率明显增加;若患者合并糖尿病或使用升压药,将增加肾毒性的风险。
[Abstract]:Objective to investigate the relationship between the concentration of vancomycin in serum and renal toxicity, the impact on prognosis and increase the risk of renal toxicity factors. Methods to choose the standard of hospitalization in 105 cases of intravenous vancomycin and monitoring the blood concentration of patients, collected from patients with gender, age, site of infection, Distribution Department, etiological examination etc. statistical data, vancomycin trough concentrations, the incidence of renal toxicity and the peak concentration of different concentration; according to whether the renal toxicity of vancomycin during treatment is divided into kidney injury group and non injury group, compared 2 groups of vancomycin trough concentrations, peak concentration, serum creatinine values before and after treatment, the creatinine clearance rate, comorbidities, and the use of antibiotics and other drugs. 105 cases of patients with a total of 125 cases of blood concentration monitoring results, the renal toxicity of 20 mg/L and the minimum concentration of more than 20 mg/L were 7.57% and 46.15%, two The difference was statistically significant (P0.05). The median Valley concentration up to 26.1 mg/L renal injury group, non injury group median 13.2 mg/L, kidney injury group was significantly higher than that of non injury group (P0.05); kidney injury combined with diabetes and the proportion of use of vasopressors were significantly higher than those in non injury group (P 0.05) of gram. Positive bacterial infection in 40 cases after vancomycin treatment, the clinical effective rate was 57.5%; the bacterial clearance rate was 32.5%, no clearance rate was 20%, the pathogenic bacteria to gram negative bacteria in 3 cases, 16 cases were not. The risk of high concentrations of vancomycin trough conclusion can increase renal toxicity, kidney toxicity occurred more than 20mg/L concentration the rate increased significantly; if patients with diabetes or the use of vasopressors, will increase the risk of renal toxicity.
【作者单位】: 上海交通大学医学院附属新华医院;
【基金】:上海市科学技术委员会基金项目(13ZR1426500) 2013—2014年度国家临床重点专科建设项目
【分类号】:R969
【相似文献】
相关期刊论文 前10条
1 刘军,赵敏;氨基糖苷类抗生素的肾毒性及降低肾毒性的对策[J];国外医药(抗生素分册);2003年06期
2 闫长会;施畅;董延生;丁日高;廖明阳;;先导化合物肾毒性早期筛选模型的初步建立[J];中国药理学与毒理学杂志;2013年03期
3 陈伟英,尹培达;氨基糖甙类抗生素肾毒性及防治近况[J];国外医学(内科学分册);1989年08期
4 舒文,刘云海;药物肾毒性不可忽视[J];医药导报;1997年02期
5 范兴忠,李宏,李新东;新型免疫抑制剂肾毒性的研究进展[J];国外医学.泌尿系统分册;2000年S1期
6 ;必须提高对中草药肾毒性的认识[J];糖尿病新世界;2000年03期
7 唐晓虹;许国章;;头孢菌素肾毒性发生机制及预防途径[J];国外医学.泌尿系统分册;1991年02期
8 杨亚东,杨友成;硫酸妥布霉素注射液的肾毒性观察[J];中国抗生素杂志;1997年06期
9 张惠荣,尹晓文,李设华,陈丽佳,唐真明;丁胺卡那霉素肾毒性的初步探讨[J];石河子医学院学报;1997年02期
10 文吉秋;季曙明;;雷帕霉素减轻神经钙蛋白抑制剂的肾毒性[J];肾脏病与透析肾移植杂志;2007年03期
相关会议论文 前7条
1 张峰;王志鹏;滕增辉;张蓉;杨铁虹;刘莉;梅其炳;;药物肾毒性筛选细胞模型的建立[A];药学发展前沿论坛及药理学博士论坛论文集[C];2008年
2 马t,
本文编号:1692505
本文链接:https://www.wllwen.com/yixuelunwen/yiyaoxuelunwen/1692505.html